Power Law company profile

Dicerna Pharmaceuticals

Biotech & Life Sciences · Watertown, United States · Founded 2007 · IPO 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.30B

Market cap · 2026

Revenue

$191M

Latest reported FY

Investors

11 investors on Dicerna Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Abingworth

Skyline Ventures

Kyowa Kirin

Oxford Bioscience Partners

Series B+ 7 investors entered at this stage

RA Capital Management

Patent intelligence

$97M patent portfolio · 85 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$97M

3.0% of market cap · 8× smaller than top peer BioNTech ($780M)

85 active patent families

Where Dicerna Pharmaceuticals innovates Molecular biologyOligonucleotideCell biologyDicerBiochemistry

Above peer median on Legal, Market

Quality vs same-sector peers

Dicerna Pharmaceuticals on the five Patsnap quality dimensions

Dicerna Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Dicerna Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Dicerna Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Dicerna Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo